The Managing Director and Chairperson of BDR Pharmaceutical, Dharmesh Shah, stated that they are planning to expand their manufacturing buyouts with the US investment of $100 million.
Gland Pharma Limited based in Hyderabad received approval from the United States Food and Drug Administration (USFDA) to develop its Abbreviated New Drug Application (ANDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024% at its facilities...
Zydus Lifesciences Ltd has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market the generic version of Niacin extended-release tablets, a cholesterol-lowering medication...
The "Pharmacists winning Team", a panel running for the state pharmacy council election with the support of the chemists and druggists association (TN CDA).
The Ministry of Ayush has been sought by the parliamentary panel on Health and Family welfare to ensure effective implementation of various practices
On April 24, 2025, the fixation of a Standard Input Output Norm for Doxycycline 100 mg dispersible tablets under the chemical and Allied products category comes under product code ‘A’.
.jpg)
Aurobindo Pharma Limited shares declined by 3.5% on Tuesday, April 29, following the news of a fire outbreak at its penicillin-G plant in the Kakinada SEZ in Andhra Pradesh during the evening of April 27, 2025...
INREROR, the French company, is planning to strengthen ties with Indian pharmaceutical manufacturers.
Dr. Reddy's Laboratories is preparing to enter the rapidly expanding GLP-1 (glucagon-like peptide-1) drug market, hoping to launch generic versions of key diabetes and obesity drugs such as Semaglutide...
The Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization to Entod Pharmaceuticals, a multinational research-driven ophthalmic firm, for a novel ocular formulation designed
, CDSCO.jpg)
